EMEA-000669-PIP01-09-M02

Key facts

Invented name
Humenza
Active substance
Split influenza virus, inactivated containing antigen equivalent to A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-179A)), adjuvanted
Therapeutic area
Vaccines
Decision number
P/0022/2019
PIP number
EMEA-000669-PIP01-09-M02
Pharmaceutical form(s)
Suspension and emulsion for injection
Condition(s) / indication(s)
Prevention of influenza
Route(s) of administration
Intramuscular use
Contact for public enquiries
Applicant: Sanofi Pasteur SA

E-mail: Piplan@sanofipasteur.com
Country: France
Phone: +33 437375038

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating